NeuBase Therapeutics, Inc. Accounts Payable
NeuBase Therapeutics, Inc. had Accounts Payable of $258.64 thousand as of 2023-09-30, per its 10-Q filed 2023-11-09.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2023-11-09
- 2023-09-30: Accounts Payable, Current $258.64K.
- 2023-06-30: Accounts Payable, Current $322.13K.
- 2023-03-31: Accounts Payable, Current $590.19K.
- 2022-12-31: Accounts Payable, Current $369.50K.
| Period end | Accounts Payable, Current |
|---|---|
| 2023-09-30 | $258.64K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $322.13K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $590.19K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $369.50K 10-Q · filed 2023-11-09 |
| 2022-09-30 | $1.84M 10-QT · filed 2023-06-05 |
| 2022-06-30 | $1.66M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $1.62M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $1.19M 10-Q · filed 2022-02-11 |
| 2021-09-30 | $1.81M 10-K · filed 2022-12-21 |
| 2021-06-30 | $1.52M 10-Q · filed 2021-08-13 |
| 2021-03-31 | $2.18M 10-Q · filed 2021-05-14 |
| 2020-12-31 | $1.18M 10-Q · filed 2021-02-11 |
| 2020-09-30 | $1.51M 10-K · filed 2021-12-23 |
| 2020-06-30 | $1.31M 10-Q · filed 2020-08-13 |
| 2020-03-31 | $1.66M 10-Q · filed 2020-05-14 |
| 2019-12-31 | $1.37M 10-Q · filed 2020-03-26 |
| 2019-09-30 | $1.48M 10-K · filed 2020-12-23 |
| 2018-09-30 | $21.68K 10-K · filed 2020-01-10 |